Pharmacokinetics of a Model Organic Nitrite Inhalant and its Alcohol Metabolite in Rats

Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics o...

Full description

Saved in:
Bibliographic Details
Published inDrug metabolism and disposition Vol. 28; no. 4; pp. 386 - 391
Main Authors Kielbasa, William, Fung, Ho-Leung
Format Journal Article
LanguageEnglish
Published Bethesda, MD Elsevier Inc 01.04.2000
American Society for Pharmacology and Experimental Therapeutics
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t1/2 inh = 1.5 min versus t1/2 i.v. = 5.3 min; P < .001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration.
AbstractList Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t(1/2) inh = 1.5 min versus t(1/2) i.v. = 5.3 min; P <.001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration.Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t(1/2) inh = 1.5 min versus t(1/2) i.v. = 5.3 min; P <.001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration.
Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t1/2 inh = 1.5 min versus t1/2 i.v. = 5.3 min; P < .001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration.
Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t(1/2) inh = 1.5 min versus t(1/2) i.v. = 5.3 min; P <.001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration.
Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold ( t 1/2 inh = 1.5 min versus t 1/2 i.v. = 5.3 min; P < .001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration.
Author Fung, Ho-Leung
Kielbasa, William
Author_xml – sequence: 1
  givenname: William
  surname: Kielbasa
  fullname: Kielbasa, William
– sequence: 2
  givenname: Ho-Leung
  surname: Fung
  fullname: Fung, Ho-Leung
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1315821$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10725305$$D View this record in MEDLINE/PubMed
BookMark eNqF0U1vFCEYB3Biauy2-hE0HLTRwygwMDPEg2kaW5u01vgSvZFnGNjBsrAC26bfvrPd9SVeeuLA7_9Anv8e2gkxGISeUvKaEtq8-UKIJJUUonnJ-CsqiOAVf4BmVDBaTXc_dtDsD9lFezn_JIRyXstHaJeSlomaiBn6_mmEtAAdL10wxemMo8WAz-NgPL5IcwhO44-uJFcMPg0jeAgFQxiwKxkfeh3H6PG5KdBHvzYu4M9Q8mP00ILP5sn23Effjt9_PfpQnV2cnB4dnlWaM1IqTrqhJqA7IwkwOoi6a6FrWi6EbLUFa6CXVlhJeSNFb4H1pG_7DpreckJsvY8ONnOXKf5amVzUwmVt_PRNE1dZtURKRimZ4LMtXPULM6hlcgtIN-r3KibwfAsga_A2QdAu_3U1FR2jExMbplPMORn7zyS1bkbdNaPWa1eMq7tmFJ9yb__LaVeguBhKAufvTb_YpEc3H69dMmq57c3H-Y1ineKq7prJvds4M-38ypmksnYmaDNMGV3UEN09L90C5Kyzdg
CODEN DMDSAI
CitedBy_id crossref_primary_10_1208_aapsj0903032
crossref_primary_10_1016_j_niox_2005_09_010
crossref_primary_10_1016_j_bcp_2011_04_005
crossref_primary_10_1007_s11481_006_9024_4
Cites_doi 10.1007/978-1-4615-5347-2_29
10.1097/00001648-199205000-00004
10.1056/NEJM198806163182404
10.1016/S0378-4347(99)00331-X
10.1002/jps.2600740719
10.1016/S0022-3565(25)20352-4
10.1093/occmed/44.3.125
10.1016/S0006-2952(96)00602-8
10.1006/faat.1994.1122
10.1023/A:1018943613122
10.1016/S0140-6736(02)51392-1
10.1016/S0002-8703(66)80007-8
10.1093/oxfordjournals.aje.a116186
ContentType Journal Article
Copyright 2000 American Society for Pharmacology and Experimental Therapeutics
2000 INIST-CNRS
Copyright_xml – notice: 2000 American Society for Pharmacology and Experimental Therapeutics
– notice: 2000 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/S0090-9556(24)15054-4
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-009X
EndPage 391
ExternalDocumentID 10725305
1315821
10_1016_S0090_9556_24_15054_4
28_4_386
S0090955624150544
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: HL22273
GroupedDBID ---
.GJ
0R~
18M
2WC
4.4
53G
5GY
5RE
5VS
AAXUO
ABJNI
ABSQV
ACGFO
ACGFS
ACIWK
ACPRK
ADBBV
AENEX
AERNN
AFFNX
AFOSN
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
F9R
FDB
GX1
H13
HZ~
IH2
INIJC
KQ8
LSO
M41
O9-
OK1
P2P
R0Z
RHI
ROL
RPT
SJN
TR2
VH1
W8F
WH7
WOQ
YCJ
YHG
ZGI
ZXP
~KM
-
08R
0R
AAPBV
AAWZA
ABFLS
ABSGY
ADACO
FH7
FRP
GJ
HZ
KM
O0-
RHF
W2D
AALRI
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c420t-408d30ac8e90a21d5387a86745597cfafeab9f5f914695bfa2b0b7b8a6bf400f3
ISSN 0090-9556
IngestDate Sun Aug 24 03:59:55 EDT 2025
Wed Feb 19 01:43:19 EST 2025
Mon Jul 21 09:18:47 EDT 2025
Tue Jul 01 05:41:45 EDT 2025
Thu Apr 24 23:04:01 EDT 2025
Tue Jan 05 21:16:59 EST 2021
Sun Apr 06 06:52:59 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords NO
ISBA
ISBN
ISAN
Volatile compound
Intravenous administration
Rat
Metabolite
Nitrites
Rodentia
Metabolism
Inhalation
Toxicokinetics
Vertebrata
Mammalia
Animal
Distribution
Organic nitrate
Models
Drug of abuse
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c420t-408d30ac8e90a21d5387a86745597cfafeab9f5f914695bfa2b0b7b8a6bf400f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 10725305
PQID 70992110
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_70992110
pubmed_primary_10725305
pascalfrancis_primary_1315821
crossref_primary_10_1016_S0090_9556_24_15054_4
crossref_citationtrail_10_1016_S0090_9556_24_15054_4
highwire_pharmacology_28_4_386
elsevier_sciencedirect_doi_10_1016_S0090_9556_24_15054_4
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2000-04-01
PublicationDateYYYYMMDD 2000-04-01
PublicationDate_xml – month: 04
  year: 2000
  text: 2000-04-01
  day: 01
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
PublicationTitle Drug metabolism and disposition
PublicationTitleAlternate Drug Metab Dispos
PublicationYear 2000
Publisher Elsevier Inc
American Society for Pharmacology and Experimental Therapeutics
Publisher_xml – name: Elsevier Inc
– name: American Society for Pharmacology and Experimental Therapeutics
References de Leon, Perloff (bib6) 1965; 72
Akerboom, Ji, Wagner, Sies (bib1) 1997; 53
Archibald, Schechter, Le, Craib, Montaner, O’Shaughnessy (bib2) 1993; 3
Farris, Griffith (bib7) 1949
Kowaluk, Fung (bib9) 1991; 259
Kielbasa, Bauer, Fung (bib8) 1999; 734
Bauer, Fung (bib3) 1995; 7
Seague, Mayer, Horsburgh, Holmberg, Moon, Lamb (bib15) 1992; 135
Slaughter, Coleman, Gaudette, McKee, Masten, Gardiner, Strother, Tyler, Jeffcoat (bib16) 1994; 23
Maickel, McFadden (bib11) 1979; 26
Brunton (bib4) 1867; 2
National Institute on Drug Abuse (1996) www.nida.nih.gov/NIDACapsules/NCInhalants.html
Osterloh, Goldfield (bib14) 1984; 74
Davies, Morris (bib5) 1993; 10
Soderberg, Roy, Barnett (bib17) 1998; 437
Lembo, Dell’Italia, Crawford, O’Rourke (bib10) 1988; 318
Nicholson, Ferguson-Smith, Pemberton, Campbell, Edwards, Ferner (bib13) 1994; 44
Brunton (10.1016/S0090-9556(24)15054-4_bib4) 1867; 2
de Leon (10.1016/S0090-9556(24)15054-4_bib6) 1965; 72
Davies (10.1016/S0090-9556(24)15054-4_bib5) 1993; 10
Kielbasa (10.1016/S0090-9556(24)15054-4_bib8) 1999; 734
Kowaluk (10.1016/S0090-9556(24)15054-4_bib9) 1991; 259
Lembo (10.1016/S0090-9556(24)15054-4_bib10) 1988; 318
Nicholson (10.1016/S0090-9556(24)15054-4_bib13) 1994; 44
Akerboom (10.1016/S0090-9556(24)15054-4_bib1) 1997; 53
Maickel (10.1016/S0090-9556(24)15054-4_bib11) 1979; 26
10.1016/S0090-9556(24)15054-4_bib12
Soderberg (10.1016/S0090-9556(24)15054-4_bib17) 1998; 437
Archibald (10.1016/S0090-9556(24)15054-4_bib2) 1993; 3
Farris (10.1016/S0090-9556(24)15054-4_bib7) 1949
Osterloh (10.1016/S0090-9556(24)15054-4_bib14) 1984; 74
Seague (10.1016/S0090-9556(24)15054-4_bib15) 1992; 135
Bauer (10.1016/S0090-9556(24)15054-4_bib3) 1995; 7
Slaughter (10.1016/S0090-9556(24)15054-4_bib16) 1994; 23
References_xml – volume: 734
  start-page: 83
  year: 1999
  end-page: 89
  ident: bib8
  article-title: Analysis of isobutyl nitrite inhalant in rat and human blood: Application for pharmacokinetic investigations.
  publication-title: J Chromatogr B
– volume: 259
  start-page: 519
  year: 1991
  end-page: 525
  ident: bib9
  article-title: Vascular nitric oxide activities for organic nitrites and organic nitrates are distinct.
  publication-title: J Pharmacol Exp Ther
– volume: 7
  start-page: 17
  year: 1995
  end-page: 22
  ident: bib3
  article-title: Non-nitrate nitric oxide donors.
  publication-title: J Myocard Isch
– volume: 44
  start-page: 125
  year: 1994
  end-page: 128
  ident: bib13
  article-title: Time to discontinue the solutions A and B as a cyanide antidote.
  publication-title: Occup Med
– volume: 23
  start-page: 407
  year: 1994
  end-page: 420
  ident: bib16
  article-title: Disposition and pharmacokinetics of isopropanol in F-344 rats and B6C3F1 mice.
  publication-title: Fundam Appl Toxicol
– volume: 318
  start-page: 1572
  year: 1988
  end-page: 1578
  ident: bib10
  article-title: Bedside diagnosis of systolic murmurs.
  publication-title: N Engl J Med
– volume: 135
  start-page: 1
  year: 1992
  end-page: 11
  ident: bib15
  article-title: The relation between nitrite inhalants, unprotected receptive anal intercourse, and the risk of human immunodeficiency virus infection.
  publication-title: Am J Epidemiol
– volume: 2
  start-page: 97
  year: 1867
  ident: bib4
  article-title: On the use of nitrite of amyl in angina pectoris.
  publication-title: Lancet
– volume: 74
  start-page: 780
  year: 1984
  end-page: 782
  ident: bib14
  article-title: Uptake of inhaled n-butyl nitrite and in vivo transformation in rats.
  publication-title: J Pharm Sci
– volume: 53
  start-page: 117
  year: 1997
  end-page: 120
  ident: bib1
  article-title: Subunit specificity and organ distribution of glutathione transferase-catalysed s-nitrosoglutathione formation from alkyl nitrites in the rat.
  publication-title: Biochem Pharmacol
– volume: 437
  start-page: 265
  year: 1998
  end-page: 268
  ident: bib17
  article-title: Isobutyl nitrite liberates nitric oxide which is not responsible for the immunotoxicity of the inhalant.
  publication-title: Adv Exp Med Biol
– reference: National Institute on Drug Abuse (1996) www.nida.nih.gov/NIDACapsules/NCInhalants.html
– volume: 26
  start-page: 75
  year: 1979
  end-page: 83
  ident: bib11
  article-title: Acute toxicology of butyl nitrites and butyl alcohols.
  publication-title: Res Comm Chem Pathol Pharmacol
– volume: 3
  start-page: 203
  year: 1993
  end-page: 209
  ident: bib2
  article-title: Evidence for a sexually transmitted co-factor for AIDS-related Kaposi’s Sarcoma in a cohort of homosexual men.
  publication-title: Epidemiol
– volume: 72
  start-page: 337
  year: 1965
  end-page: 344
  ident: bib6
  article-title: The pulmonary hemodynamic effects of amyl nitrite in normal man.
  publication-title: Am Heart J
– volume: 10
  start-page: 1093
  year: 1993
  end-page: 1095
  ident: bib5
  article-title: Physiological parameters in laboratory animals and humans.
  publication-title: Pharm Res
– year: 1949
  ident: bib7
  article-title: The Rat in Laboratory Investigation
– volume: 437
  start-page: 265
  year: 1998
  ident: 10.1016/S0090-9556(24)15054-4_bib17
  article-title: Isobutyl nitrite liberates nitric oxide which is not responsible for the immunotoxicity of the inhalant.
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-1-4615-5347-2_29
– volume: 3
  start-page: 203
  year: 1993
  ident: 10.1016/S0090-9556(24)15054-4_bib2
  article-title: Evidence for a sexually transmitted co-factor for AIDS-related Kaposi’s Sarcoma in a cohort of homosexual men.
  publication-title: Epidemiol
  doi: 10.1097/00001648-199205000-00004
– volume: 318
  start-page: 1572
  year: 1988
  ident: 10.1016/S0090-9556(24)15054-4_bib10
  article-title: Bedside diagnosis of systolic murmurs.
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198806163182404
– ident: 10.1016/S0090-9556(24)15054-4_bib12
– year: 1949
  ident: 10.1016/S0090-9556(24)15054-4_bib7
– volume: 734
  start-page: 83
  year: 1999
  ident: 10.1016/S0090-9556(24)15054-4_bib8
  article-title: Analysis of isobutyl nitrite inhalant in rat and human blood: Application for pharmacokinetic investigations.
  publication-title: J Chromatogr B
  doi: 10.1016/S0378-4347(99)00331-X
– volume: 74
  start-page: 780
  year: 1984
  ident: 10.1016/S0090-9556(24)15054-4_bib14
  article-title: Uptake of inhaled n-butyl nitrite and in vivo transformation in rats.
  publication-title: J Pharm Sci
  doi: 10.1002/jps.2600740719
– volume: 259
  start-page: 519
  year: 1991
  ident: 10.1016/S0090-9556(24)15054-4_bib9
  article-title: Vascular nitric oxide activities for organic nitrites and organic nitrates are distinct.
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)20352-4
– volume: 44
  start-page: 125
  year: 1994
  ident: 10.1016/S0090-9556(24)15054-4_bib13
  article-title: Time to discontinue the solutions A and B as a cyanide antidote.
  publication-title: Occup Med
  doi: 10.1093/occmed/44.3.125
– volume: 53
  start-page: 117
  year: 1997
  ident: 10.1016/S0090-9556(24)15054-4_bib1
  article-title: Subunit specificity and organ distribution of glutathione transferase-catalysed s-nitrosoglutathione formation from alkyl nitrites in the rat.
  publication-title: Biochem Pharmacol
  doi: 10.1016/S0006-2952(96)00602-8
– volume: 7
  start-page: 17
  year: 1995
  ident: 10.1016/S0090-9556(24)15054-4_bib3
  article-title: Non-nitrate nitric oxide donors.
  publication-title: J Myocard Isch
– volume: 23
  start-page: 407
  year: 1994
  ident: 10.1016/S0090-9556(24)15054-4_bib16
  article-title: Disposition and pharmacokinetics of isopropanol in F-344 rats and B6C3F1 mice.
  publication-title: Fundam Appl Toxicol
  doi: 10.1006/faat.1994.1122
– volume: 10
  start-page: 1093
  year: 1993
  ident: 10.1016/S0090-9556(24)15054-4_bib5
  article-title: Physiological parameters in laboratory animals and humans.
  publication-title: Pharm Res
  doi: 10.1023/A:1018943613122
– volume: 2
  start-page: 97
  year: 1867
  ident: 10.1016/S0090-9556(24)15054-4_bib4
  article-title: On the use of nitrite of amyl in angina pectoris.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)51392-1
– volume: 72
  start-page: 337
  year: 1965
  ident: 10.1016/S0090-9556(24)15054-4_bib6
  article-title: The pulmonary hemodynamic effects of amyl nitrite in normal man.
  publication-title: Am Heart J
  doi: 10.1016/S0002-8703(66)80007-8
– volume: 135
  start-page: 1
  year: 1992
  ident: 10.1016/S0090-9556(24)15054-4_bib15
  article-title: The relation between nitrite inhalants, unprotected receptive anal intercourse, and the risk of human immunodeficiency virus infection.
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a116186
– volume: 26
  start-page: 75
  year: 1979
  ident: 10.1016/S0090-9556(24)15054-4_bib11
  article-title: Acute toxicology of butyl nitrites and butyl alcohols.
  publication-title: Res Comm Chem Pathol Pharmacol
SSID ssj0014439
Score 1.6606156
Snippet Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used...
Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used...
SourceID proquest
pubmed
pascalfrancis
crossref
highwire
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 386
SubjectTerms Administration, Inhalation
Alcohols - blood
Alcohols - metabolism
Animals
Biological and medical sciences
Biotransformation
Cardiac Output - drug effects
Drug addictions
Half-Life
Infusions, Intravenous
Male
Medical sciences
Nitrites - administration & dosage
Nitrites - blood
Nitrites - pharmacokinetics
Rats
Rats, Sprague-Dawley
Toxicology
Vasodilator Agents - administration & dosage
Vasodilator Agents - blood
Vasodilator Agents - pharmacokinetics
Title Pharmacokinetics of a Model Organic Nitrite Inhalant and its Alcohol Metabolite in Rats
URI https://dx.doi.org/10.1016/S0090-9556(24)15054-4
http://dmd.aspetjournals.org/content/28/4/386.abstract
https://www.ncbi.nlm.nih.gov/pubmed/10725305
https://www.proquest.com/docview/70992110
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfKuHBBfBNgwweYQFu6xHES-1igqMBAQ2vFbpadxICY2mlND3DmD-c5dhJ3MBW4RG1kx21-Pz-_Z78PhJ5UWcUynaowzZIypCWNQlbCfCwUlTLjvCyJCXB-_yGbzOjbk_RkMPjpeS2tajUsfvwxruR_UIV7gKuJkv0HZLuHwg34DPjCFRCG619hfOTyTn8DVbFJt9wEOzbFbVy5pmIPpizY_yY1yBfjxVh3pwXSFsc1NaSBCKe2zR4QYukrrK_OV5-7Jq6eRvm18_Xq5PWb8eGL0fGoc9lrODGzAVGTYXi4trsQeU4pvUO_kTSeD-lRn1Tb5oga-8UIpn3cmL_dGPEo5KlNIt5KXsI8hlFPjCZtemz7zdbz-k3Y232H4-7RoJIT-pRw0HFT6mKH1hJsX1j4OnfEOIlNvPAVdJWAsWGk5buP_VkUpYk1otwwfRzYQT_2M0Kfu3Ev03C6BNTG_1YuYQpqWzvlcuOmUXKmN9B1Z53gkaXaTTSo5rfQrkPi-z723_o-3sU-RrfRp4t8xAuNJW74iB0fseMjbvmIAVoMfMSOj7jnI7TBho930Oz1ePpyErrCHWFBSVSHNGJlEsmCVTySJC5hUc0ly3JqzNdCS11JxXWqOSzTPFVaEhWpXDGZKQ1rik7uoq35Yl7dR7hQmdYszxVnBWj2BYujRFck50wnYKzEAaLtyxaFy2pviqucit59ETASBiNBqGgwEjRAw67bmU3rsqkDa5EUTje1OqcANm7qutMiL848WARhggqgeoC21_jQ_yLLywA9bvkhQPibEz05rxarpcjBvjM7OAG6Z2nj_ZmcpLCWP9jw7IfoWj_tH6Gt-nxVbYOaXaudZhb8AoHB0Gw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetics+of+a+model+organic+nitrite+inhalant+and+its+alcohol+metabolite+in+rats&rft.jtitle=Drug+metabolism+and+disposition&rft.au=KIELBASA%2C+W&rft.au=FUNG%2C+H.-L&rft.date=2000-04-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0090-9556&rft.volume=28&rft.issue=4&rft.spage=386&rft.epage=391&rft_id=info:doi/10.1016%2FS0090-9556%2824%2915054-4&rft.externalDBID=n%2Fa&rft.externalDocID=1315821
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-9556&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-9556&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-9556&client=summon